PPP
DXCM icon

Private Portfolio Partners’s DexCom DXCM Stock Holding History

Private Portfolio Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,980
Closed -$253K – 271
2022
Q1 		$253K Buy
1,980
+196
+11% +$21.4K 0.06% 244
2021
Q4 		$239K Buy
1,784
+44
+3% +$6.32K 0.06% 246
2021
Q3 		$238K Buy
+1,740
New +$219K 0.07% 227
2020
Q4 		– Sell
-2,256
Closed -$232K – 225
2020
Q3 		$232K Hold
2,256
– – 0.09% 183
2020
Q2 		$229K Buy
+2,256
New +$202K 0.11% 166

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Portfolio Partners's DXCM Position: Q2 2022 in Review

Private Portfolio Partners sold out of DexCom (DXCM) in Q2 2022, closing a stake of 1,980 shares — an estimated $253K sold.

Private Portfolio Partners first reported a position in DXCM in Q2 2020 and held it in 5 quarters. The position peaked at $253K in Q1 2022. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Private Portfolio Partners reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Private Portfolio Partners sold 1,980 DexCom shares in Q2 2022, an estimated $253K.
  • Private Portfolio Partners first reported a position in DexCom in Q2 2020 and held it in 5 quarters.
  • Private Portfolio Partners's DexCom position peaked at $253K in Q1 2022.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Private Portfolio Partners's 13F filing for Q2 2022, filed 2 Aug 2022.